A nuclear inhibitor of NF-κB encoded by a poxvirus

Journal of Virology

Volumn 85, Issue 1, 2011, Pages 264-275

  Diel, D G ^a,b   Luo, S ^a   Delhon, G ^c   Peng, Y ^a,d   Flores, E F ^b   Rock, D L ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^c UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^d SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B; LIPOPOLYSACCHARIDE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; VIRUS PROTEIN;

ACETYLATION; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; INHIBITION KINETICS; NATURAL HOST; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SHEEP; VIRUS GENOME; VIRUS PATHOGENESIS; VIRUS VIRULENCE; WILD TYPE;

ANIMALS; CELL NUCLEUS; CELLS, CULTURED; ECTHYMA, CONTAGIOUS; GENE EXPRESSION REGULATION; NF-KAPPA B; ORF VIRUS; SHEEP; SIGNAL TRANSDUCTION; VIRAL PROTEINS;

ORF VIRUS; OVIS ARIES; POXVIRIDAE;

EID: 78650072718     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01149-10     Document Type: Article

References (49)

1. Bartlett, N., J. A. Symons, D. C. Tscharke, and G. L. Smith. 2002. The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence. J. Gen. Virol. 83:1965-1976.
2. Bowie, A., E. Kiss-Toth, J. A. Symons, G. L. Smith, S. K. Dower, and L. A. O'Neill. 2000. A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc. Natl. Acad. Sci. U. S. A. 97:10162-10167.
3. Buerki, C., K. M. Rothgiesser, T. Valovka, H. R. Owen, H. Rehrauer, M. Fey, W. S. Lane, and M. O. Hottiger. 2008. Functional relevance of novel p300-mediated lysine 314 and 315 acetylation of RelA/p65. Nucleic Acids Res. 36:1665-1680.
4. Camus-Bouclainville, C., L. Fiette, S. Bouchiha, B. Pignolet, D. Counor, C. Filipe, J. Gelfi, and F. Messud-Petit. 2004. A virulence factor of myxoma virus colocalizes with NF-kappaB in the nucleus and interferes with inflammation. J. Virol. 78:2510-2516.
5. Chang, S. J., J. C. Hsiao, S. Sonnberg, C. T. Chiang, M. H. Yang, D. L. Tzou, A. A. Mercer, and W. Chang. 2009. Poxvirus host range protein CP77 contains an F-box-like domain that is necessary to suppress NF-kappaB activation by tumor necrosis factor alpha but is independent of its host range function. J. Virol. 83:4140-4152.
6. Chen, L. F., and W. C. Greene. 2003. Regulation of distinct biological activities of the NF-kappaB transcription factor complex by acetylation. J. Mol. Med. 81:549-557.
7. Chen, L. F., and W. C. Greene. 2004. Shaping the nuclear action of NF-kappaB. Nat. Rev. Mol. Cell Biol. 5:392-401.
8. Chen, L. F., Y. Mu, and W. C. Greene. 2002. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J. 21:6539-6548.
9. Chen, L. F., S. A. Williams, Y. Mu, H. Nakano, J. M. Duerr, L. Buckbinder, and W. C. Greene. 2005. NF-kappaB RelA phosphorylation regulates RelA acetylation. Mol. Cell. Biol. 25:7966-7975.
10. Chen, R. A., N. Jacobs, and G. L. Smith. 2006. Vaccinia virus strain Western Reserve protein B14 is an intracellular virulence factor. J. Gen. Virol. 87:1451-1458.
11. Chen, R. A., G. Ryzhakov, S. Cooray, F. Randow, and G. L. Smith. 2008. Inhibition of IkappaB kinase by vaccinia virus virulence factor B14. PLoS Pathog. 4:e22.
12. Delhon, G., E. R. Tulman, C. L. Afonso, Z. Lu, A. de la Concha-Bermejillo, H. D. Lehmkuhl, M. E. Piccone, G. F. Kutish, and D. L. Rock. 2004. Genomes of the parapoxviruses ORF virus and bovine papular stomatitis virus. J. Virol. 78:168-177.
13. Diel, D. G., G. Delhon, S. Luo, E. F. Flores, and D. L. Rock. 2010. A novel inhibitor of the NF-kappaB signaling pathway encoded by the parapoxvirus orf virus. J. Virol. 84:3962-3973.
14. DiPerna, G., J. Stack, A. G. Bowie, A. Boyd, G. Kotwal, Z. Zhang, S. Arvikar, E. Latz, K. A. Fitzgerald, and W. L. Marshall. 2004. Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like receptors. J. Biol. Chem. 279:36570-36578.
15. Dvoracek, B., and T. Shors. 2003. Construction of a novel set of transfer vectors to study vaccinia virus replication and foreign gene expression. Plasmid 49:9-17.
16. Ea, C. K., and D. Baltimore. 2009. Regulation of NF-kappaB activity through lysine monomethylation of p65. Proc. Natl. Acad. Sci. U. S. A. 106:18972-18977.
17. Erickson, G. A., E. A. Carbrey, and G. A. Gustafson. 1975. Generalized contagious ecthyma in a sheep rancher: diagnostic considerations. J. Am. Vet. Med. Assoc. 166:262-263.
18. Fleming, S. B., D. M. Haig, P. Nettleton, H. W. Reid, C. A. McCaughan, L. M. Wise, and A. Mercer. 2000. Sequence and functional analysis of a homolog of interleukin-10 encoded by the parapoxvirus orf virus. Virus Genes 21:85-95.
19. Fleming, S. B., and A. A. Mercer. 2007. Genus Parapoxvirus, p. 127-165. In A. A. Mercer, A. Schmidt, and O. Weber (ed.), Poxviruses. Birkhäuser, Basel, Switzerland.
20. Gedey, R., X. L. Jin, O. Hinthong, and J. L. Shisler. 2006. Poxviral regulation of the host NF-kappaB response: the vaccinia virus M2L protein inhibits induction of NF-kappaB activation via an ERK2 pathway in virus-infected human embryonic kidney cells. J. Virol. 80:8676-8685.
21. Granja, A. G., M. L. Nogal, C. Hurtado, C. Del Aguila, A. L. Carrascosa, M. L. Salas, M. Fresno, and Y. Revilla. 2006. The viral protein A238L inhibits TNF-alpha expression through a CBP/p300 transcriptional coactivators pathway. J. Immunol. 176:451-462.
22. Granja, A. G., P. Sabina, M. L. Salas, M. Fresno, and Y. Revilla. 2006. Regulation of inducible nitric oxide synthase expression by viral A238L-mediated inhibition of p65/RelA acetylation and p300 transactivation. J. Virol. 80:10487-10496.
23. Haig, D. M., and A. A. Mercer. 1998. Ovine diseases. Orf. Vet. Res. 29:311-326.
24. Harte, M. T., I. R. Haga, G. Maloney, P. Gray, P. C. Reading, N. W. Bartlett, G. L. Smith, A. Bowie, and L. A. O'Neill. 2003. The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J. Exp. Med. 197:343-351.
25. Huang, B., X. D. Yang, M. M. Zhou, K. Ozato, and L. F. Chen. 2009. Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA. Mol. Cell. Biol. 29:1375-1387.
26. Iketani, Y., Y. Inoshima, A. Asano, K. Murakami, S. Shimizu, and H. Sentsui. 2002. Persistent parapoxvirus infection in cattle. Microbiol. Immunol. 46:285-291.
27. Jenkinson, D. M., P. E. McEwan, V. A. Moss, H. Y. Elder, and H. W. Reid. 1990. Location and spread of orf virus antigen in infected ovine skin. Vet. Dermatol. 1:189-195.
28. Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18:621-663.
29. Kiernan, R., V. Bres, R. W. Ng, M. P. Coudart, S. El Messaoudi, C. Sardet, D. Y. Jin, S. Emiliani, and M. Benkirane. 2003. Post-activation turn-off of NF-kappaB-dependent transcription is regulated by acetylation of p65. J. Biol. Chem. 278:2758-2766.
30. Meechan, J. G., and R. I. MacLeod. 1992. Human labial orf: a case report. Br. Dent. J. 173:343-344.
31. Mohamed, M. R., and G. McFadden. 2009. NF-kappaB inhibitors: strategies from poxviruses. Cell Cycle 8:3125-3132.
32. Mohamed, M. R., M. M. Rahman, A. Rice, R. W. Moyer, S. J. Werden, and G. McFadden. 2009. Cowpox virus expresses a novel ankyrin repeat NF-kappaB inhibitor that controls inflammatory cell influx into virus-infected tissues and is critical for virus pathogenesis. J. Virol. 83:9223-9236.
33. Moss, B. 2007. Poxviruses: the viruses and their replication, p. 2905-2946. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 5th ed., vol. 2. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, PA.
34. Murao, L. E., and J. L. Shisler. 2005. The MCV MC159 protein inhibits late, but not early, events of TNF-alpha-induced NF-kappaB activation. Virology 340:255-264.
35. Myskiw, C., J. Arsenio, R. van Bruggen, Y. Deschambault, and J. Cao. 2009. Vaccinia virus E3 suppresses expression of diverse cytokines through inhibition of the PKR, NF-kappaB, and IRF3 pathways. J. Virol. 83:6757-6768.
36. Nestle, F. O., P. Di Meglio, J. Z. Qin, and B. J. Nickoloff. 2009. Skin immune sentinels in health and disease. Nat. Rev. Immunol. 9:679-691.
37. Nettleton, P. F., J. A. Gilray, D. L. Yirrell, G. R. Scott, and H. W. Reid. 1996. Natural transmission of orf virus from clinically normal ewes to orf-naive sheep. Vet. Rec. 139:364-366.
38. Nichols, D. B., and J. L. Shisler. 2009. Poxvirus MC160 protein utilizes multiple mechanisms to inhibit NF-kappaB activation mediated via components of the tumor necrosis factor receptor 1 signal transduction pathway. J. Virol. 83:3162-3174.
39. Pasparakis, M. 2009. Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases. Nat. Rev. Immunol. 9:778-788.
40. Perkins, N. D. 2006. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene 25:6717-6730. (Pubitemid 44657848)
41. Rebholz, B., I. Haase, B. Eckelt, S. Paxian, M. J. Flaig, K. Ghoreschi, S. A. Nedospasov, R. Mailhammer, S. Debey-Pascher, J. L. Schultze, G. Weindl, I. Forster, R. Huss, A. Stratis, T. Ruzicka, M. Rocken, K. Pfeffer, R. M. Schmid, and R. A. Rupec. 2007. Crosstalk between keratinocytes and adaptive immune cells in an IkappaBalpha protein-mediated inflammatory disease of the skin. Immunity 27:296-307.
42. Sanchez, R. L., A. Hebert, H. Lucia, and J. Swedo. 1985. Orf. A case report with histologic, electron microscopic, and immunoperoxidase studies. Arch. Pathol. Lab. Med. 109:166-170.
43. Shisler, J. L., and X. L. Jin. 2004. The vaccinia virus K1L gene product inhibits host NF-kappaB activation by preventing IkappaBalpha degradation. J. Virol. 78:3553-3560.
44. Smale, S. T. 2010. Selective transcription in response to an inflammatory stimulus. Cell 140:833-844.
45. Smith, G. L. 2007. Genus Orthopoxvirus: Vaccinia virus, p. 1-45. In A. A. Mercer, A. Schmidt, and O. Weber (ed.), Poxviruses. Birkhäuser, Basel, Switzerland.
46. Stack, J., I. R. Haga, M. Schroder, N. W. Bartlett, G. Maloney, P. C. Reading, K. A. Fitzgerald, G. L. Smith, and A. G. Bowie. 2005. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. J. Exp. Med. 201:1007-1018.
47. Vallabhapurapu, S., and M. Karin. 2009. Regulation and function of NF-kappaB transcription factors in the immune system. Annu. Rev. Immunol. 27:693-733.
48. Wan, F., and M. J. Lenardo. 2010. The nuclear signaling of NF-kappaB: current knowledge, new insights, and future perspectives. Cell Res. 20:24-33.
49. Westphal, D., E. C. Ledgerwood, M. H. Hibma, S. B. Fleming, E. M. Whelan, and A. A. Mercer. 2007. A novel Bcl-2-like inhibitor of apoptosis is encoded by the parapoxvirus ORF virus. J. Virol. 81:7178-7188.